Minh-Thao Tu, Hoejun Kwon, Yoon-Jung Choi, Hyunsoon Cho
{"title":"人口老龄化导致的预期癌症负担:来自快速老龄化社会的洞察。","authors":"Minh-Thao Tu, Hoejun Kwon, Yoon-Jung Choi, Hyunsoon Cho","doi":"10.1002/ijc.70125","DOIUrl":null,"url":null,"abstract":"<p><p>Population aging is an increasing challenge for cancer control in rapidly aging societies, yet remains inadequately quantified. We aim to project and illustrate the cancer burden attributable to aging in Korea by utilizing age-period-cohort (APC) models and population attributable fraction (PAF) concepts. From population-based cancer data, incidence and mortality of cancers primarily affected by aging (stomach, colorectal, liver, gallbladder, pancreatic, lung, non-Hodgkin lymphoma, esophagus, prostate, ovarian, male bladder cancers, and female leukemia) and breast cancer were extracted. Aging-attributable fraction, cases, and deaths were estimated for older ages after projection to 2046 by APC models. Future cancer landscapes were projected to evolve due to population aging. While aging-related lung cancer may remain the highest (from 2017-2021: 94,990 cases, 71,726 deaths, PAF<sub>mortality</sub> 78%; to 2042-2046: 220,251 cases, PAF<sub>incidence</sub> 78%, 114,476 deaths, PAF<sub>mortality</sub> 88%), the current high burden of stomach and liver cancers, likely related to infection, will shift to older age with reduced aging-attributable cases but increased PAF<sub>incidence</sub>. Emerging burden will arise from lifestyle-related cancers, including colorectal cancer mortality (mortality-to-incidence ratio [MIR] of age ≥65 0.41 to 0.46) and prostate and breast cancer incidence (for age ≥65: 60,099 to 228,539 cases, PAF<sub>incidence</sub> 74% to 86%; and 1316 to 31,874 cases, PAF<sub>incidence</sub> 1% to 22%, respectively). Our findings highlight the coexistence of traditional and emerging burdens, which should be key priorities for cancer control programs when societies enter the upcoming super-aged decades. Efforts to mitigate forecasted trends are urgently required, including cancer prevention targeting middle-aged adults and cancer care for frail older patients.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Projected cancer burden attributable to population aging: Insight from a rapidly aging society.\",\"authors\":\"Minh-Thao Tu, Hoejun Kwon, Yoon-Jung Choi, Hyunsoon Cho\",\"doi\":\"10.1002/ijc.70125\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Population aging is an increasing challenge for cancer control in rapidly aging societies, yet remains inadequately quantified. We aim to project and illustrate the cancer burden attributable to aging in Korea by utilizing age-period-cohort (APC) models and population attributable fraction (PAF) concepts. From population-based cancer data, incidence and mortality of cancers primarily affected by aging (stomach, colorectal, liver, gallbladder, pancreatic, lung, non-Hodgkin lymphoma, esophagus, prostate, ovarian, male bladder cancers, and female leukemia) and breast cancer were extracted. Aging-attributable fraction, cases, and deaths were estimated for older ages after projection to 2046 by APC models. Future cancer landscapes were projected to evolve due to population aging. While aging-related lung cancer may remain the highest (from 2017-2021: 94,990 cases, 71,726 deaths, PAF<sub>mortality</sub> 78%; to 2042-2046: 220,251 cases, PAF<sub>incidence</sub> 78%, 114,476 deaths, PAF<sub>mortality</sub> 88%), the current high burden of stomach and liver cancers, likely related to infection, will shift to older age with reduced aging-attributable cases but increased PAF<sub>incidence</sub>. Emerging burden will arise from lifestyle-related cancers, including colorectal cancer mortality (mortality-to-incidence ratio [MIR] of age ≥65 0.41 to 0.46) and prostate and breast cancer incidence (for age ≥65: 60,099 to 228,539 cases, PAF<sub>incidence</sub> 74% to 86%; and 1316 to 31,874 cases, PAF<sub>incidence</sub> 1% to 22%, respectively). Our findings highlight the coexistence of traditional and emerging burdens, which should be key priorities for cancer control programs when societies enter the upcoming super-aged decades. Efforts to mitigate forecasted trends are urgently required, including cancer prevention targeting middle-aged adults and cancer care for frail older patients.</p>\",\"PeriodicalId\":180,\"journal\":{\"name\":\"International Journal of Cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ijc.70125\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ijc.70125","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Projected cancer burden attributable to population aging: Insight from a rapidly aging society.
Population aging is an increasing challenge for cancer control in rapidly aging societies, yet remains inadequately quantified. We aim to project and illustrate the cancer burden attributable to aging in Korea by utilizing age-period-cohort (APC) models and population attributable fraction (PAF) concepts. From population-based cancer data, incidence and mortality of cancers primarily affected by aging (stomach, colorectal, liver, gallbladder, pancreatic, lung, non-Hodgkin lymphoma, esophagus, prostate, ovarian, male bladder cancers, and female leukemia) and breast cancer were extracted. Aging-attributable fraction, cases, and deaths were estimated for older ages after projection to 2046 by APC models. Future cancer landscapes were projected to evolve due to population aging. While aging-related lung cancer may remain the highest (from 2017-2021: 94,990 cases, 71,726 deaths, PAFmortality 78%; to 2042-2046: 220,251 cases, PAFincidence 78%, 114,476 deaths, PAFmortality 88%), the current high burden of stomach and liver cancers, likely related to infection, will shift to older age with reduced aging-attributable cases but increased PAFincidence. Emerging burden will arise from lifestyle-related cancers, including colorectal cancer mortality (mortality-to-incidence ratio [MIR] of age ≥65 0.41 to 0.46) and prostate and breast cancer incidence (for age ≥65: 60,099 to 228,539 cases, PAFincidence 74% to 86%; and 1316 to 31,874 cases, PAFincidence 1% to 22%, respectively). Our findings highlight the coexistence of traditional and emerging burdens, which should be key priorities for cancer control programs when societies enter the upcoming super-aged decades. Efforts to mitigate forecasted trends are urgently required, including cancer prevention targeting middle-aged adults and cancer care for frail older patients.
期刊介绍:
The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories:
-Cancer Epidemiology-
Cancer Genetics and Epigenetics-
Infectious Causes of Cancer-
Innovative Tools and Methods-
Molecular Cancer Biology-
Tumor Immunology and Microenvironment-
Tumor Markers and Signatures-
Cancer Therapy and Prevention